Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAQ4 Class: Corporate Bond - Foreign US$

Pacer Advisors, Inc.'s Holding History (CIK: 0001616667)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 100,000 Value ($000) $101 Avg Close — Range —
Q3 2025
Shares 80,000 Value ($000) $80 Avg Close — Range —
Q2 2025
Shares 145,000 Value ($000) $146 Avg Close — Range —
Q1 2025
Shares 70,000 Value ($000) $68 Avg Close — Range —
Q4 2024
Shares 166,000 Value ($000) $162 Avg Close — Range —
Q2 2024
Shares 118,000 Value ($000) $113 Avg Close — Range —
Q1 2024
Shares 194,000 Value ($000) $186 Avg Close — Range —
Q4 2023
Shares 194,000 Value ($000) $186 Avg Close — Range —
Q3 2023
Shares 194,000 Value ($000) $175 Avg Close — Range —
Q2 2023
Shares 194,000 Value ($000) $176 Avg Close — Range —